Vericel Corporation Is A Publicly Traded Biopharmaceutical Company Based In Cambridgemassachusettsfounded In 1989The Company Specializes In Developing And Marketing Advanced Cell Therapiesit Was Previously Known As Aastrom Biosciences And Underwent Significant Transformation After Acquiring Sanofi S Cell Therapy And Regenerative Medicine Business In 2014 Vericel S Product Portfolio Includes Several Innovative Cell Therapiesmaci Is An Autologous Chondrocyte Implant For Treating Knee Cartilage Defects And Was The First Tissue Engineered Product Approved By Both The European Medicines Agency And The Fdacarticel Is Another Autologous Chondrocyte Implant For Knee Cartilage Defectsrecognized As The First Cell Therapy To Receive Biologics License Application Approvalepicel Is Used For Permanent Skin Replacement In Patients With Severe Burnswhile Nexobrid Is Licensed For Treating Severe Thermal Burns In North Americavericel Markets Its Products Primarily To Orthopedic Surgeons And Specialized Burn Centersfocusing On Personalized Medicine To Meet Individual Patient Needs
